4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-25-016734
CHIEF OPERATING OFFICER sold 6,667 shares at an average $20.34 ($135,574)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Patel Anish · CHIEF OPERATING OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-09 | Sale : show line 1 in the form 10b5-1 | −6,607 | $20.33 | $134,304 | 303,369 | I |
| 2025-06-09 | Sale : show line 2 in the form 10b5-1 | −60 | $21.16 | $1,270 | 303,309 | I |
| Open-market sales · 6,667 sh · avg $20.34 · $135,574 | ||||||
Loading xslF345X05/form4-06112025_100610.xml…